Cullinan Therapeutics, Inc. (CGEM)
9.70
-0.28
(-2.81%)
USD |
NASDAQ |
Dec 19, 16:00
9.70
0.00 (0.00%)
After-Hours: 17:20
Cullinan Therapeutics EPS Diluted (Quarterly): -0.8567 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Black Diamond Therapeutics, Inc. | -0.1493 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.61M |
| Total Expenses (Quarterly) | 50.61M |
| Enterprise Value | 258.17M |
| Earnings Yield | -37.94% |
| Normalized Earnings Yield | -37.94 |